Mpox and Viral Co‐Infections: A Narrative Review
Health Science Reports · 2025-02 · 8 (2)
DOI: 10.1002/hsr2.70464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 25.02.2025. Verfasst von Mohsen Nakhaie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Ira…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Monkeypox (Mpox), caused by the monkeypox virus (MPXV), has emerged as a significant global public health concern, particularly following a substantial multi‐country outbreak in mid‐2022. The World Health Organization (WHO) reported 109,699 laboratory‐confirmed Mpox cases and 236 fatalities worldwide from January 1, 2022, to September 30, 2024. This narrative review aims to evaluate the co‐infections of Mpox with various viral agents and assess their implications for public health.
Methods
We conducted a comprehensive review of the literature regarding Mpox co‐infections with human immunodeficiency virus (HIV), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), hepatitis viruses (hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV)), and herpesviruses (including herpes simplex virus (HSV)‐1, HSV‐2, varicella‐zoster virus (VZV), and cytomegalovirus (CMV)).
Results
We analyzed epidemiological trends, clinical manifestations, preventive measures, treatment guidelines, and advanced diagnostic methodologies. The review highlights the intricate dynamics of Mpox co‐infections and underscores the necessity for comprehensive diagnostic approaches, including viral load assays, to evaluate active co‐infections, particularly for HIV and HBV.
Conclusion
Understanding the interplay between MPXV and other viral pathogens is crucial for enhancing management strategies for co‐infections. By addressing these complexities, we aim to contribute valuable insights into the public health implications of Mpox co‐infections and improve response strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences Kerman University of Medical Sciences Kerman Iran.
- Clinical Research Development Unit, Afzalipour Hospital Kerman University of Medical Sciences Kerman Iran.
- Universal Scientific Education and Research Network (USERN) Tehran Iran.
- Department of Hematology and Blood Banking, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran.
- Student Research Committee Jiroft University of Medical Sciences Jiroft Iran.
- Department of Microbiology, Faculty of Medicine Shahid Sadoughi University of Medical Sciences Yazd Iran.
ORCID-Profile: Mohsen Nakhaie, Niloofar Farsiu, Nasir Arefinia
Zitieren
APA
Nakhaie, M., Rukerd, M. R. Z., Farsiu, N., Bashash, D., Mahani, F. K., Arefinia, N., Charostad, J., Zarei, M., & Behnezhad, F. (2025). Mpox and Viral Co‐Infections: A Narrative Review. Health Science Reports, 8(2). https://doi.org/10.1002/hsr2.70464
Vancouver
Nakhaie M, Rukerd MRZ, Farsiu N, Bashash D, Mahani FK, Arefinia N, et al. Mpox and Viral Co‐Infections: A Narrative Review. Health Science Reports. 2025;8(2). doi:10.1002/hsr2.70464
BibTeX
@article{Nakhaie2025,
author = {Nakhaie, Mohsen and Rukerd, Mohammad Rezaei Zadeh and Farsiu, Niloofar and Bashash, Davood and Mahani, Fatemeh Khodadadpour and Arefinia, Nasir and Charostad, Javad and Zarei, Mohammad and Behnezhad, Farzane},
title = {Mpox and Viral Co‐Infections: A Narrative Review},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {2},
doi = {10.1002/hsr2.70464}
}
EUVIMED